WHO ICTRP trial
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants…
JPRN-jRCT2071220078 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2071220078 |
|---|---|
| Public title | Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 1) |
| Scientific title | Phase 3 Multicenter, Randomized, Double Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Nucleos(t)ide Analogue treated Participants with Chronic Hepatitis B Virus (B-Well 1) - B-Well 1 |
| Primary sponsor | Okawa Yasutoshi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Canada;Japan;Argentina;Japan;Brazil;Japan;Bulgaria;Japan;China;Japan;France;Japan;Germany;Japan;Greece;Japan;Hong… |
| Conditions | Chronic Hepatitis B |
| Interventions | -Bepirovirsen -Placebo |
| Registration date | Aug 12, 2022 |
| Target size | 900 |
| Secondary IDs | NCT05630807 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: